Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA expands use of Gilead's liver drug to rare subset of patients
FDA expands use of Gilead's liver drug to rare subset of patients
FDA expands use of Gilead's liver drug to rare subset of patients
Submitted by
admin
on February 16, 2016 - 10:28am
Source:
Yahoo/Reuters
News Tags:
FDA
Gilead Sciences
Harvoni
Headline:
FDA expands use of Gilead's liver drug to rare subset of patients
Do Not Allow Advertisers to Use My Personal information
